FDA
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
FDA
May 7, 2024, 04:39 |
Blog
Sinan Sarac: Parexel will be heavily represented at ASCO24
Sinan Sarac, Vice President of Regulatory Strategy at Parexel, shared a post on LinkedIn: "I…
May 5, 2024, 12:26 |
Blog
Albert Bourla: Some highlights from Pfizer’s 2024 Q1 financial results
Albert Bourla, Chairman and Chief Executive Officer at Pfizer, shared a post on LinkedIn: "Today, I…
May 3, 2024, 05:06 |
Opinion
Vincent Rajkumar on the Importance of Accelerated Approval for Cancer Treatment
Vincent Rajkumar, Editor in Chief of Blood Cancer Journal, shared on X: "On Accelerated Approval…
May 3, 2024, 04:43 |
Blog
Wafik El-Deiry: This is very sad to see in 2024 in the US
Karen Knudsen recently shared a post by the American Cancer Society Cancer Action Network on X/Twitter, adding:…
May 2, 2024, 14:43 |
Blog
Wishing everyone a great time, particularly the participants of OncoDaily's party - Advanced Oncology
Advanced Oncology shared a post by Sinan B. Sarac, Vice President of Regulatory Strategy at…
May 2, 2024, 13:23 |
Insight
Marco Donia: Welcoming the Era of Gene Editing in Medicine
Marco Donia, Clinical Research Associate Professor at the University of Copenhagen, shared on LinkedIn: "Autologous…
May 2, 2024, 02:53 |
Drugs
FDA approves lutetium Lu 177 dotatate for pediatric patients 12 years and older with GEP-NETS
FDA Approves the First Radioactive Drug for Pediatric Neuroendocrine Tumors the U.S. Food and Drug…
May 1, 2024, 12:17 |
Insight
David R. Liu: The first prime editing clinical trial has been cleared by U.S. FDA to begin
David R. Liu, Core Institute Member and Vice-Chair of the Faculty at Broad Institute of MIT…
May 1, 2024, 12:12 |
Blog
FDA has cleared Prime Medicine's PM359 for the treatment of chronic granulomatous disease
Prime Medicine shared on X/Twitter: "We are pleased to announce that FDA has cleared our IND…
May 1, 2024, 10:55 |
Blog
Tanja Obradovic: The spotlight of FDA last week
Tanja Obradovic, Vice President of Oncology Scientific Affairs at ICON plc., shared a post on LinkedIn:…
1
2
3
4
5
All:
138
Posts:
11 - 20
OncoInfluencers: Dialogue with Rob Pieters, hosted by Shushan Hovsepyan
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Facebook
RSS Feed
Twitter
Linkedin
Youtube